Radar Therapeutics develops programmable genetic medicines that use RNA biology and computation to control where and when therapeutic payloads are expressed
Radar Therapeutics develops programmable genetic medicines that use RNA biology and computation to control where and when therapeutic payloads are expressed. Its platform aims to enable precise, responsive treatments for diseases including cancer, autoimmune disorders, and diseases of the brain and senses.